Recombinant Escherichia fergusonii L-threonine 3-dehydrogenase (tdh)

Shipped with Ice Packs
In Stock

Product Specs

Form
Lyophilized powder. We will preferentially ship the available format, but please specify any format requirements when ordering.
Lead Time
Delivery times vary by purchase method and location. Consult your local distributor for specifics. Proteins are shipped with blue ice packs. Request dry ice in advance (extra fees apply).
Notes
Avoid repeated freeze-thaw cycles. Store working aliquots at 4°C for up to one week.
Reconstitution
Briefly centrifuge the vial before opening. Reconstitute in sterile deionized water to 0.1-1.0 mg/mL. Add 5-50% glycerol (final concentration) and aliquot for long-term storage at -20°C/-80°C. Our default final glycerol concentration is 50%.
Shelf Life
Shelf life depends on storage conditions, buffer, temperature, and protein stability. Liquid form: 6 months at -20°C/-80°C. Lyophilized form: 12 months at -20°C/-80°C.
Storage Condition
Store at -20°C/-80°C upon receipt. Aliquot for multiple uses. Avoid repeated freeze-thaw cycles.
Tag Info
Tag type is determined during manufacturing. Specify your preferred tag type, and we will prioritize its development.
Synonyms
tdh; EFER_3906; L-threonine 3-dehydrogenase; TDH; EC 1.1.1.103
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Expression Region
1-341
Protein Length
full length protein
Purity
>85% (SDS-PAGE)
Species
Escherichia fergusonii (strain ATCC 35469 / DSM 13698 / CDC 0568-73)
Target Names
tdh
Target Protein Sequence
MKALSKLKAE EGIWMTDVPE PELGHNDLLI KIRKTAICGT DVHIYNWDEW SQKTIPVPMV VGHEYVGEVV GIGQEVKGFK IGDRVSGEGH ITCGHCRNCR AGRTHLCRNT IGVGVNRPGC FAEYLVIPAF NAFKIPDNIS DDLASIFDPF GNAVHTALSF DLVGEDVLVS GAGPIGIMAA AVAKHVGARN VVITDVNEYR LELARKMGIT RAVNVAKENL EDVMAELGMT EGFDVGLEMS GAPAAFRTML DTMNHGGRIA MLGIPPSDMS IDWTKVIFKG LFIKGIYGRE MFETWYKMAA LIQSGLDLSP IITHRFSIDD FQKGFDAMRS GQSGKVILSW D
Uniprot No.

Target Background

Function
Catalyzes the NAD(+)-dependent oxidation of L-threonine to 2-amino-3-ketobutyrate.
Database Links
Protein Families
Zinc-containing alcohol dehydrogenase family
Subcellular Location
Cytoplasm.

Q&A

What is L-threonine 3-dehydrogenase and what is its primary function?

L-threonine 3-dehydrogenase (TDH) is an NAD+-dependent enzyme that catalyzes the dehydrogenation of the hydroxyl group of L-threonine to produce 2-amino-3-ketobutyrate (AKB). This represents the initial step in L-threonine metabolism in many prokaryotes, including Escherichia fergusonii . TDH belongs to the short-chain dehydrogenase/reductase family and exhibits high specificity toward L-threonine as a substrate . The enzyme plays a crucial role in amino acid metabolism, and in some organisms, the products of this reaction contribute to lipid synthesis and antioxidant production .

How does E. fergusonii TDH differ from TDH in other bacterial species?

While specific structural information for E. fergusonii TDH is limited in the current literature, comparative analyses with other bacterial TDH enzymes reveal both conserved features and species-specific variations. Sequence analysis of TDH across different bacterial species, including Clostridium difficile, Flavobacterium frigidimaris, and Thermoplasma volcanum, shows identity percentages ranging from 39% to 48% . These differences may influence substrate specificity, catalytic efficiency, and quaternary structure, with some TDHs functioning as monomers (as seen in metagenome-derived TDH) while others exist as dimers (such as C. difficile TDH) .

What are the general structural characteristics of bacterial TDH enzymes?

Bacterial TDH enzymes typically consist of an N-terminal Rossmann-fold domain responsible for NAD+ binding and a C-terminal catalytic domain. X-ray crystallography studies of TDH from C. difficile at 2.6 Å resolution have confirmed this two-domain architecture . Many bacterial TDHs are dimeric, with the constituent monomers interacting via their Rossmann-fold domains, although monomeric forms have also been identified through both crystal structure analysis and gel-filtration chromatography . The active site undergoes conformational changes between open and closed states upon substrate binding, which is crucial for regulating substrate specificity .

Why is there research interest in recombinant E. fergusonii expressing TDH?

E. fergusonii has emerged as a valuable model organism for genetic engineering due to its close relation to E. coli and its utility in studying metabolic pathways . Recombinant E. fergusonii strains have been successfully developed to express various enzymatic pathways, making it a promising platform for investigating TDH function in a controlled genetic background . Additionally, since TDH plays roles in metabolic pathways that are present in many pathogens but absent in humans, understanding its function in recombinant bacterial systems could contribute to the development of antimicrobial strategies .

What methodologies are most effective for expressing and purifying recombinant E. fergusonii TDH?

For optimal expression of recombinant TDH from E. fergusonii, a molecular cloning approach utilizing the pET expression system has proven effective for similar bacterial TDH enzymes. The methodology involves:

  • Gene amplification using PCR with primers designed to introduce appropriate restriction sites (such as NdeI and BamHI)

  • Cloning into an expression vector like pET-16b

  • Transformation into expression strains such as E. coli BL21(DE3)

  • Expression of His-tagged enzyme for simplified purification

For purification, immobilized metal affinity chromatography (IMAC) using Ni-NTA resin offers high-yield purification of the His-tagged enzyme, followed by size-exclusion chromatography to remove aggregates and ensure homogeneity. When expressing TDH, considerations should be made regarding temperature (typically 25-30°C) and induction conditions to maximize soluble protein yield .

How can one assess the enzymatic activity and kinetic parameters of recombinant E. fergusonii TDH?

Enzymatic activity of TDH can be measured spectrophotometrically by monitoring the reduction of NAD+ to NADH at 340 nm during the oxidation of L-threonine to 2-amino-3-ketobutyrate. A typical reaction mixture contains:

ComponentConcentration
Tris-HCl buffer (pH 8.4)100 mM
NAD+2.0 mM
L-threonineVariable (0.1-10 mM for kinetic studies)
Purified TDH1-5 μg/ml

Kinetic parameters (Km, kcat, kcat/Km) can be determined using the Michaelis-Menten equation, with substrate concentrations varied to ensure coverage of values below and above the Km. Temperature and pH optimization studies should also be conducted to determine the optimal conditions for enzyme activity . Site-directed mutagenesis of key active site residues (analogous to S74, S111, Y136, T177, D179 in other TDH enzymes) can provide valuable insights into the catalytic mechanism and substrate specificity .

What experimental approaches can elucidate the structure-function relationship of E. fergusonii TDH?

A comprehensive approach to understanding the structure-function relationship of E. fergusonii TDH should include:

  • X-ray crystallography of multiple enzyme states:

    • Apoenzyme structure

    • Binary complex with NAD+

    • Ternary complex with NAD+ and L-threonine or other substrates

    • Product-bound complex with NADH and 2-amino-3-ketobutyrate

  • Computational analysis:

    • Molecular dynamics simulations to study protein flexibility

    • Quantum mechanical calculations such as Fragment Molecular Orbital (FMO) method to analyze Inter-Fragment Interaction Energy (IFIE)

    • Homology modeling based on related TDH structures when crystallographic data is unavailable

  • Mutagenesis studies:

    • Alanine scanning of active site residues

    • Targeted mutations based on structural information

    • Analysis of mutant enzymes for activity, substrate specificity, and thermostability

These approaches collectively provide insights into substrate binding, catalytic mechanism, conformational changes during catalysis, and the molecular basis of substrate specificity.

How do different expression systems affect the folding and activity of recombinant E. fergusonii TDH?

The expression system significantly impacts the folding, stability, and activity of recombinant TDH enzymes. Recent studies on related biochemical pathways have demonstrated that proper protein folding often requires specific chaperones . For instance, when expressing proteins that function at physiological temperature (37°C), co-expression with chaperones like GroES/EL can enhance proper folding and enzyme activity .

Different expression hosts may yield varying results:

Expression HostAdvantagesLimitations
E. coli BL21(DE3)High yield, simple cultivationMay form inclusion bodies with some proteins
E. fergusoniiNative post-translational modificationsLower transformation efficiency
Cold-adapted expression strainsBetter folding of thermolabile proteinsLower protein yield

Temperature optimization is crucial, as expression at lower temperatures (16-25°C) often improves solubility but reduces yield. The addition of stabilizing agents like glycerol or specific ions during purification can also enhance enzyme stability .

What strategies can overcome expression challenges for recombinant E. fergusonii TDH?

When encountering expression challenges with recombinant E. fergusonii TDH, consider implementing these strategies:

  • Codon optimization: Analyze the codon usage bias in E. fergusonii and optimize the TDH gene sequence accordingly to enhance translation efficiency.

  • Chaperone co-expression: Co-express molecular chaperones such as GroES/EL, which have been demonstrated to enhance the proper folding of proteins at physiological temperatures (37°C) .

  • Fusion tags beyond His-tag: Consider fusion with solubility-enhancing tags such as MBP (maltose-binding protein), GST (glutathione S-transferase), or SUMO.

  • Expression temperature optimization: Test expression at various temperatures (16°C, 25°C, 30°C, 37°C) to identify conditions that balance protein yield and solubility.

  • Induction optimization: Vary IPTG concentration (0.1-1.0 mM) and induction time to identify optimal conditions for soluble protein production.

  • Media supplementation: Add cofactors or stabilizing agents such as glycerol, sorbitol, or specific metal ions to the growth media to enhance protein stability during expression .

How can researchers effectively study the substrate specificity of E. fergusonii TDH?

To comprehensively analyze the substrate specificity of E. fergusonii TDH, researchers should employ a multi-faceted approach:

  • Substrate screening:

    • Test a panel of structurally related compounds including L-threonine analogs, other amino acids, and alcohols

    • Measure activity using the standard NAD+ reduction assay

    • Calculate relative activity compared to L-threonine as the reference substrate

  • Kinetic analysis:

    • Determine kinetic parameters (Km, kcat, kcat/Km) for promising alternative substrates

    • Compare specificity constants (kcat/Km) to quantify substrate preference

  • Structural analysis:

    • Obtain crystal structures of TDH in complex with different substrates

    • Analyze binding interactions using computational methods

    • Identify key residues involved in substrate recognition

  • Site-directed mutagenesis:

    • Target residues in the substrate-binding pocket identified through structural studies

    • Analyze changes in substrate preference resulting from mutations

    • Engineer variants with altered specificity

What analytical techniques are most informative for characterizing the reaction products of E. fergusonii TDH?

To accurately characterize the reaction products of E. fergusonii TDH, researchers should employ multiple complementary analytical techniques:

  • Spectrophotometric methods:

    • Continuous monitoring of NADH formation at 340 nm provides real-time reaction kinetics

    • Coupled enzyme assays with 2-amino-3-ketobutyrate CoA-ligase (KBL) can track the complete conversion pathway

  • Chromatographic methods:

    • HPLC analysis with appropriate columns for amino acid separation

    • LC-MS for definitive identification of 2-amino-3-ketobutyrate and potential side products

    • GC-MS for volatile products after appropriate derivatization

  • NMR spectroscopy:

    • 1H and 13C NMR for structural confirmation of reaction products

    • Real-time NMR to monitor reaction progress and identify intermediates

  • Mass spectrometry:

    • ESI-MS for molecular weight determination of non-volatile products

    • Multiple reaction monitoring (MRM) for quantitative analysis of specific products

These techniques collectively provide comprehensive characterization of reaction products, enabling researchers to fully understand the catalytic mechanism and potential side reactions .

How can researchers design experiments to study the role of E. fergusonii TDH in metabolic pathways?

To effectively investigate the role of E. fergusonii TDH in metabolic pathways, researchers should implement a systematic experimental design:

  • Gene knockout and complementation studies:

    • Generate tdh knockout strains of E. fergusonii

    • Complement with wild-type or mutant tdh genes

    • Assess growth phenotypes under various nutritional conditions

  • Metabolomics analysis:

    • Compare metabolite profiles between wild-type, tdh knockout, and complemented strains

    • Utilize targeted and untargeted LC-MS/MS approaches to identify changes in key metabolites

    • Track isotopically labeled threonine to follow metabolic flux

  • Systems biology approaches:

    • Perform transcriptomics to identify genes co-regulated with tdh

    • Analyze proteomics data to identify changes in protein expression related to threonine metabolism

    • Integrate data using pathway analysis tools

  • In vivo models:

    • Utilize recombinant E. fergusonii strains in gnotobiotic mice to study metabolic pathways in a controlled in vivo environment

    • Design strains that constitutively express tdh to eliminate the need for induction through exogenous chemical inducers

  • Comparative genomics:

    • Analyze tdh genes and their genomic context across related bacterial species

    • Identify conserved regulatory elements and potential metabolic partners

What are the potential applications of recombinant E. fergusonii TDH in therapeutic development?

The absence of a functional TDH gene in humans presents opportunities for targeting this enzyme in pathogenic organisms . Potential therapeutic applications include:

  • Antimicrobial development:

    • TDH inhibitors could selectively target pathogens that rely on this enzyme

    • Structure-based drug design using crystal structures of bacterial TDH can facilitate inhibitor development

    • Compounds like tetraethylthiuram disulfide (antabuse) have shown inhibitory effects against TDH in some organisms

  • Metabolic intervention:

    • In organisms where TDH contributes to essential metabolic processes (such as fatty acid synthesis in Trypanosoma brucei), inhibition could have therapeutic effects

    • Combined inhibition of TDH with other metabolic enzymes might have synergistic effects

  • Probiotics and microbiome modulation:

    • Engineered E. fergusonii strains with modified TDH activity could potentially influence gut microbiome metabolism

    • Such applications would require thorough safety assessments given the potential pathogenicity of some E. fergusonii strains

How can advanced structural biology techniques enhance our understanding of E. fergusonii TDH?

Cutting-edge structural biology techniques can provide unprecedented insights into E. fergusonii TDH structure and function:

  • Cryo-electron microscopy (cryo-EM):

    • Allows visualization of TDH in different conformational states

    • Enables structure determination without crystallization, potentially capturing more physiologically relevant states

    • Particularly useful for studying TDH in complex with other proteins or membrane components

  • Time-resolved crystallography:

    • Captures structural changes during catalysis

    • Provides insights into reaction intermediates and conformational changes

    • Helps elucidate the complete catalytic mechanism

  • Hydrogen-deuterium exchange mass spectrometry (HDX-MS):

    • Maps protein dynamics and conformational changes

    • Identifies regions of flexibility important for catalysis

    • Complements static structural techniques

  • Nuclear magnetic resonance (NMR) spectroscopy:

    • Analyzes protein dynamics in solution

    • Characterizes substrate binding and product release

    • Particularly valuable for studying the monomeric forms of TDH

These techniques collectively would provide a comprehensive understanding of the structure-function relationship of E. fergusonii TDH, informing both basic research and applied studies.

How can researchers address stability issues with purified recombinant E. fergusonii TDH?

Stability challenges with purified TDH can significantly impact experimental outcomes. To address these issues:

  • Buffer optimization:

    • Screen various buffer compositions (HEPES, Tris, phosphate) at different pH values (7.0-8.5)

    • Include stabilizing agents such as glycerol (10-20%), reducing agents (DTT, β-mercaptoethanol), and appropriate salt concentrations

  • Storage conditions:

    • Compare stability at different temperatures (4°C, -20°C, -80°C)

    • Evaluate the impact of flash-freezing in liquid nitrogen versus slow freezing

    • Test different protein concentrations for storage

  • Cofactor addition:

    • Include NAD+ in storage buffers to stabilize the enzyme

    • Test the effect of substrate analogues on protein stability

  • Protein engineering approaches:

    • Identify unstable regions through limited proteolysis and HDX-MS

    • Introduce stabilizing mutations based on comparative sequence analysis with thermostable TDH homologs

    • Consider fusion with stability-enhancing partners

The optimal conditions determined through these systematic approaches should be consistently applied across all experiments to ensure reproducible results .

What strategies can help resolve contradictory data in E. fergusonii TDH research?

When faced with contradictory results in TDH research, implement these systematic troubleshooting approaches:

  • Methodological standardization:

    • Verify enzyme purity using multiple techniques (SDS-PAGE, mass spectrometry)

    • Standardize activity assay conditions across experiments

    • Ensure consistent protein handling procedures

  • Sources of variability analysis:

    • Examine batch-to-batch variations in enzyme preparation

    • Consider the influence of different expression systems

    • Evaluate the impact of post-translational modifications

  • Independent verification:

    • Use multiple analytical techniques to confirm key findings

    • Compare results from different experimental approaches

    • Collaborate with other laboratories for independent validation

  • Biological relevance assessment:

    • Consider whether discrepancies arise from in vitro versus in vivo conditions

    • Evaluate the impact of quaternary structure (monomeric versus dimeric forms)

    • Assess the influence of experimental conditions on enzyme behavior

A comprehensive analysis of contradictory data often reveals nuanced aspects of enzyme function that may have been previously overlooked, ultimately leading to a more complete understanding of E. fergusonii TDH.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.